logo

For the Inventor, By the Inventor

Berkshire, United Kingdom

Seqirus UK Limited


USPTO Granted Patents = 35



Trademarks = 49

Forward Citations = 32

Loading Chart...
Loading Chart...

46 inventors (with patents filed for the assignee):

goldMedal Peter W Mason (11 out of 35 patents)

silverMedal Philip R Dormitzer (10 out of 34 patents)

bronzeMedal Derek T O'Hagan (8 out of 73 patents)

4.  Pirada Suphaphiphat (7 out of 10 patents)

5.  Nicola Groth (6 out of 7 patents)

6.  Rino Rappuoli (5 out of 82 patents)

7.  Giuseppe Del Giudice (5 out of 11 patents)

8.  Heidi Trusheim (4 out of 6 patents)

9.  Mario Contorni (3 out of 20 patents)

10.  Ethan Settembre (3 out of 10 patents)

11.  Jens-Peter Gregersen (3 out of 9 patents)

12.  Raul Gomila (3 out of 3 patents)

13.  Michael Franti (3 out of 8 patents)

14.  Steven Black (2 out of 2 patents)

15.  Uwe Nicolay (2 out of 2 patents)


35 patents:

1. 12318442 - Preparation of influenza virus vaccine antigens (2025-06-03),
2. 12083175 - Enhancement of self-amplifying mRNA molecules within lipid nanoparticles (2024-09-10),
3. 11897918 - Compositions and methods to increase production (2024-02-13),
4. 11896660 - Reducing hospitalization in elderly influenza vaccine recipients (2024-02-13),
5. 11707520 - Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture (2023-07-25),
6. 11466257 - Cell-derived viral vaccines with low levels of residual cell DNA (2022-10-11),
7. 11406701 - Vaccination of immunocompromised subjects (2022-08-09),
8. 11249088 - Influenza potency assays (2022-02-15),
9. 11246921 - Influenza vaccines with reduced amounts of squalene (2022-02-15),
10. 11013795 - Antigenically matched influenza vaccines (2021-05-25),
11. 10946088 - Preparation of influenza virus vaccine antigens (2021-03-16),
12. 10864264 - Influenza virus reassortment (2020-12-15),
13. 10842867 - Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture (2020-11-24),
14. 10716844 - Vaccination of immunocompromised subjects (2020-07-21),
15. 10655108 - Cell-derived viral vaccines with low levels of residual cell DNA (2020-05-19),
Seqirus UK Limited is a global biopharmaceutical company that specializes in the research, development, manufacturing, and distribution of influenza vaccines. With a focus on public health, Seqirus aims to protect communities and save lives through the prevention of infectious diseases. As part of the Seqirus organization, they leverage their expertise to develop effective and innovative vaccines that meet the evolving needs of healthcare professionals and patients worldwide.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

35 Patents

#8 in Berkshire

#499 in United Kingdom

#18,611 in the World

...
Berkshire, United Kingdom

Seqirus UK Limited

Forward Citations = 32

46 inventors:

goldMedal Peter W Mason (11 out of 35 patents)

silverMedal Philip R Dormitzer (10 out of 34 patents)

bronzeMedal Derek T O'Hagan (8 out of 73 patents)

4.  Pirada Suphaphiphat (7 out of 10 patents)

5.  Nicola Groth (6 out of 7 patents)

Please report any incorrect information to support@idiyas.com
Loading…